Detalles de la búsqueda
1.
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
N Engl J Med
; 388(18): 1645-1656, 2023 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133584
2.
Multidisciplinary blended learning to build a breast cancer specialist career: survey on the perspective of the first 2 cohorts of the ESO-ULM Certificate of Competence in Breast cancer (CCB).
BMC Med Educ
; 22(1): 344, 2022 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35513883
3.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
N Engl J Med
; 379(2): 122-137, 2018 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29863451
4.
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 122(7): 1119, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949268
5.
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Breast Cancer Res Treat
; 181(2): 347-359, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274665
6.
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99.
BMC Cancer
; 20(1): 114, 2020 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32046665
7.
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 120(10): 959-967, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30967649
8.
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
BMC Cancer
; 19(1): 902, 2019 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500588
9.
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients.
Reprod Biomed Online
; 38(5): 835-844, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30914152
10.
Diagnosis and Treatment of Breast Cancer in Young Women.
Curr Treat Options Oncol
; 20(12): 86, 2019 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31776799
11.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
N Engl J Med
; 371(2): 107-18, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24881463
12.
Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women.
Curr Treat Options Oncol
; 18(5): 28, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28439796
13.
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
Breast Cancer Res
; 18(1): 110, 2016 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825388
14.
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Breast Cancer Res Treat
; 160(3): 393-410, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27734215
15.
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Lancet Oncol
; 16(7): 848-58, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26092816
16.
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Breast Cancer Res Treat
; 154(3): 543-55, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26590813
17.
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Breast Cancer Res Treat
; 154(2): 275-86, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26493064
18.
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Breast Cancer Res Treat
; 151(2): 373-84, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935582
19.
Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations.
Genet Med
; 17(9): 726-32, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25503500
20.
Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series.
Int J Clin Oncol
; 20(1): 90-4, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24722887